2026-2034年全球医疗保健製药合约开发和生产组织（CDMO）市场规模、份额、趋势和成长分析报告

预计医疗保健合约开发和生产组织 (CDMO) 市场将从 2025 年的 3,574.8 亿美元成长到 2034 年的 1.0495 兆美元，2026 年至 2034 年的复合年增长率为 12.17%。

随着製药和生物技术公司越来越多地将药物研发和生产流程外包，全球医疗保健合约研发生产力组织（CDMO）市场正在迅速扩张。 CDMO提供广泛的服务，包括製剂开发、临床试验样本生产和大规模生产。这种外包模式使企业能够降低营运成本、提高效率并加速新治疗方法的商业化。

CDMO市场的主要驱动力之一是药物研发日益复杂化以及对专业化生产能力的需求不断增长。製药公司与CDMO合作，以利用现代药物生产所需的先进技术和法规专业知识。此外，生物製药和个人化医疗的进步也进一步增加了对专业化生产服务的需求。

未来，随着药物研发管线的扩展，CDMO市场预计将显着成长。生物製造、连续生产製程和先进药物递送系统等领域的技术创新将提升产能。此外，随着全球製药公司在全球范围内拓展生产伙伴关係关係，新兴市场预计也将在市场成长中发挥重要作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球医疗保健药品合约开发与生产组织 (CDMO) 市场：按服务分类

• 市场分析、洞察与预测
• 合约开发（小分子、聚合物、衝击波疗法）
• 契约製造（低分子量化合物、高分子量化合物、高活性原料药、最终製剂、医疗设备）

第五章 全球医疗保健製药合约开发与生产组织（CDMO）市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第六章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第七章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Catalent Inc
  • Lonza Group Ltd
  • Recipharm AB
  • Siegfried Holding AG
  • Therm Fisher Scientific Inc
  • Covance Inc
  • Jabil
  • Sanmina Corporation
  • IQVIA Holdings Inc
  • Flex

The Healthcare Contract Development and Manufacturing Organization Market size is expected to reach USD 1004.95 Billion in 2034 from USD 357.48 Billion (2025) growing at a CAGR of 12.17% during 2026-2034.

The global healthcare contract development and manufacturing organization (CDMO) market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource drug development and manufacturing processes. CDMOs provide a range of services, including drug formulation, clinical trial material production, and large-scale manufacturing. This outsourcing model helps companies reduce operational costs, improve efficiency, and accelerate the commercialization of new therapies.

One of the primary drivers of the CDMO market is the growing complexity of drug development and the increasing demand for specialized manufacturing capabilities. Pharmaceutical companies are collaborating with CDMOs to access advanced technologies and regulatory expertise required for modern drug production. Additionally, the rising development of biologics and personalized medicines is further driving the need for specialized manufacturing services.

In the future, the CDMO market is expected to grow significantly as pharmaceutical pipelines continue to expand. Technological innovations in biomanufacturing, continuous processing, and advanced drug delivery systems will enhance production capabilities. Emerging markets are also expected to play a crucial role in market growth as global pharmaceutical companies expand their manufacturing partnerships worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Contract Development (Small Molecule, Large Molecule, Shockwave Therapy)
• Contract Manufacturing (Small Molecule, Large Molecule, High Potency API, Finished Dose Formulations, Medical Devices)

COMPANIES PROFILED

• Catalent Inc, Lonza Group Ltd, Recipharm AB, Siegfried Holding AG, Therm Fisher Scientific Inc, Covance Inc, Jabil, Sanmina Corporation, IQVIA Holdings Inc, Flex
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Contract Development (Small Molecule, Large Molecule, Shockwave Therapy) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Contract Manufacturing (Small Molecule, Large Molecule, High Potency API, Finished Dose Formulations, Medical Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 5.1. Regional Outlook
• 5.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.2.1 By Services
  • 5.2.2 United States
  • 5.2.3 Canada
  • 5.2.4 Mexico
• 5.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.3.1 By Services
  • 5.3.2 United Kingdom
  • 5.3.3 France
  • 5.3.4 Germany
  • 5.3.5 Italy
  • 5.3.6 Russia
  • 5.3.7 Rest Of Europe
• 5.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.4.1 By Services
  • 5.4.2 India
  • 5.4.3 Japan
  • 5.4.4 South Korea
  • 5.4.5 Australia
  • 5.4.6 South East Asia
  • 5.4.7 Rest Of Asia Pacific
• 5.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.5.1 By Services
  • 5.5.2 Brazil
  • 5.5.3 Argentina
  • 5.5.4 Peru
  • 5.5.5 Chile
  • 5.5.6 Rest of Latin America
• 5.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 5.6.1 By Services
  • 5.6.2 Saudi Arabia
  • 5.6.3 UAE
  • 5.6.4 Israel
  • 5.6.5 South Africa
  • 5.6.6 Rest of the Middle East And Africa

Chapter 6. COMPETITIVE LANDSCAPE

• 6.1. Recent Developments
• 6.2. Company Categorization
• 6.3. Supply Chain & Channel Partners (based on availability)
• 6.4. Market Share & Positioning Analysis (based on availability)
• 6.5. Vendor Landscape (based on availability)
• 6.6. Strategy Mapping

Chapter 7. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION INDUSTRY

• 7.1. Top Companies Market Share Analysis
• 7.2. Company Profiles
  • 7.2.1 Catalent Inc
  • 7.2.2 Lonza Group Ltd
  • 7.2.3 Recipharm AB
  • 7.2.4 Siegfried Holding AG
  • 7.2.5 Therm Fisher Scientific Inc
  • 7.2.6 Covance Inc
  • 7.2.7 Jabil
  • 7.2.8 Sanmina Corporation
  • 7.2.9 IQVIA Holdings Inc
  • 7.2.10 Flex